Diindolylmethane Powder

Diindolylmethane Powder

We consistently implement steps to improve production facilities and quality of Diindolylmethane Powder. Highly demanded in the market, the provided powder is used in making various types of medicines and helps in treatment of diverse viral infections and antibiotic resistant bacteria. Offered powder is derived from the brassica vegetables such as broccoli and cauliflower. Moreover, our quality controllers check this powder in order to ensure its purity and non-toxic nature. Also, the offered Diindolylmethane Powder can be availed from us at market leading prices.

Features:

•     Longer shelf life
•     Effectiveness
•     Accurate composition
•     Purity 
  

Other Info:

•     Name  3,3'-Diindolylmethane
•     Molecular Formula  C17H14N2
•     Molecular Weight  246.31
•     CAS Registry Number  1968-05-4

Other Deatils:

Exporter of diindolylmethane powder, 3,3'-diindolylmethane, pure diindolylmethane (dim) powder an anti-carcinogen compound derived from the digestion of indole-3-carbinol, found in Brassica vegetables such as broccoli and cauliflower. The reputation of Brassica vegetables as medicinal plants rests in part on the activities of diindolylmethane.

DIM has the biological properties listed in the chart below. Because of its various potent anti-cancer properties, the National Cancer Institute of the United States has begun clinical trials of DIM as a therapeutic for numerous forms of cancer. Due to its innate immune modulating properties (potentiation of Interferon-Gamma receptors and production), DIM is also under investigation as a treatment for a variety of viral infections and antibiotic resistant bacteria As DIM has been demonstrated to synergize with Interferon-Gamma in the potentiation of the MHC-I Complex, it is currently also under investigation as an adjuvant to IFN-G treatment models for both cancer and viral infections such as HIV, HPV and Hepatitis.

DIM is currently used to treat Recurring Respiratory Papillomatosis, a rare respiratory disease with tumors in the upper respiratory tracts caused by the Human Papilloma Virus. DIM is additionally in Phase III clinical trials for Cervical dysplasia, a pre-cancerous condition also caused by the Human Papilloma Virus.

Specification: